Galderma Group N (GALD) — Working Capital to Net Assets Ratio
Galderma Group N (GALD) has a Working Capital to Net Assets ratio of 2.1% as of June 2025. Working capital of CHF160.00 Million (current assets of CHF1.91 Billion minus current liabilities of CHF1.75 Billion) is measured against net assets of CHF7.73 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Galderma Group N's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Galderma Group N Working Capital to Net Assets (2021–2024)
This chart shows how Galderma Group N's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 2.1%, reflecting working capital of CHF160.00 Million against net assets of CHF7.73 Billion CHF. Check Galderma Group N (GALD) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Galderma Group N (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Galderma Group N from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Galderma Group N market cap and net worth.
| Year | WC/NA Ratio | Working Capital (CHF) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 4.0% | CHF315.00 Million | CHF7.79 Billion | CHF1.84 Billion | CHF1.53 Billion | ▲ +3.2 pp |
| 2023 | 0.8% | CHF38.35 Million | CHF4.52 Billion | CHF1.36 Billion | CHF1.32 Billion | ▲ +11.0 pp |
| 2022 | -10.2% | CHF-420.13 Million | CHF4.13 Billion | CHF1.39 Billion | CHF1.81 Billion | ▼ -2.7 pp |
| 2021 | -7.5% | CHF-309.15 Million | CHF4.14 Billion | CHF1.38 Billion | CHF1.69 Billion | — |